Capricor Therapeutics
CAPR
#7633
Rank
โ‚น40.89 B
Marketcap
โ‚น703.29
Share price
0.80%
Change (1 day)
36.52%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2026 (TTM): -โ‚น225.23

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น227.02. In 2025 the company made an earnings per share (EPS) of -โ‚น209.41 a decrease over its 2024 EPS that were of -โ‚น111.19.

EPS history for Capricor Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น225.237.55%
2025-โ‚น209.4188.33%
2024-โ‚น111.19
2022-โ‚น109.3435.63%
2021-โ‚น80.61-7.45%
2020-โ‚น87.10-55.45%
2019-โ‚น195.51-59.81%
2018-โ‚น486.47-1850%
2017โ‚น27.80-102.94%
2016-โ‚น945.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น618.95-372.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น645.84-384.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚น559.67 146.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น403.07 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น699.58 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,714 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA